Highlights of Past EHA (HOPE) Middle East & North Africa (MENA) 2019

EHA is returning to Cairo for the 4th edition of the Highlights of Past EHA (HOPE). The meeting is organized in partnership with regional and national societies in the Middle East and North Africa.

Dates: September 12-14, 2019
Location: Cairo, Egypt

NEW English to French translation for attendees from French-speaking countries in the region.

Prof John Gribben, President, European Hematology Association (EHA)
Prof Mohamad Qari, President, Pan Arab Hematology Association (PAHA)
Prof Mervat Mattar, Vice President, Pan Arab Hematology Association (PAHA)
Prof Amal El-Beshlawy, Vice President, Egyptian Society of Hematology and Research (ESHR)
Prof Azza Kamel, Secretary General, Egyptian Society of Hematology and Research (ESHR)

HOPE MENA 2019 aims to bring the key messages from various fields of hematology of the 24th Congress of EHA to the Middle East and North Africa. Regional and local sessions are added to stimulate and encourage interaction between faculty and participants.

Register today for this exciting meeting Click here to register

Meeting objectives

Participants of HOPE MENA 2019 will be able to:

  • enhance their knowledge of evidence-based approaches on diagnosis and treatment for hematologic diseases,
  • access the latest results on clinical and translational research in hematologic disorders,
  • be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties, and
  • communicate, collaborate and network with colleagues and representatives of a large international audience from the medical industry.


The HOPE MENA 2019 program covers a variety of topics from the 24th Congress of EHA by key leaders in their fields.

Please find below an overview of the topics covered in the program:

  • Red cell & iron
  • Lymphoma
  • Leukemia
  • Gene & immunotherapy
  • White cells
  • Thrombosis
  • Laboratory diagnosis
  • Stem cells

For the full meeting program, click here.

Abstract submission

The abstract program will allow researchers and clinicians from the region to profile the work and share it with an audience of their peers.

Abstract submission has closed. For more information, click here.

Target audience

Physicians, clinicians, basic researchers, biologists, trainees, medical students and pharmaceutical companies in the Middle East and North Africa interested in the broad field of hematology, specifically those who could not attend the 24th Congress of EHA.


The European Hematology Association will award scholarships to junior doctors and students to support them in attending HOPE MENA 2019.

The scholarship application has officially closed. For more information, click here.


The meeting will take place at the Hilton Heliopolis Cairo:
El-Orouba, Sheraton Al Matar, El Nozha, Cairo, Egypt

Key dates



Online registration for HOPE MENA 2019 has opened.

For more information about registration and to register, click here.

Partner acknowledgment

EHA would like to thank the following regional and national partners for their collaboration. This supports us in realizing our educational goal of bringing the key messages from various fields of hematology of the 24th Congress of EHA to the Middle East and North Africa which contributes to the advancement of hematology education and science in the region:

Partners Hope Mena v3


We thank the following sponsors for supporting Highlights of Past EHA (HOPE) MENA 2019:

Premium level partner



Meeting partners

novartis logo pos rgb2 astrazeneca 1


2000px Logo Takeda.svg


Would you like to support this meeting? Please contact us through sponsorship@ehaweb.org so we can share the various opportunities with you.

EBAH CME Accreditation

EBAH accredited stamp DEF2

Highlights of Past EHA Middle East & North Africa (HOPE MENA) 2019 is accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of hematology. Staying abreast of these scientific developments and keeping in touch with up-to-date views on clinical policy will enable you to raise your professional level, resulting in the best treatment for your patients.